Sanjay Mhalasakant Khaladkar, Rishika Gupta, Ela Sharma, Dinesh Chouhan


Kasabach Merritt syndrome (KMS) is also known as hemangioma- thrombocytopenia syndrome. It is a rare disorder characterised by profound thrombocytopenia, microangiopathic hemolytic anemia, subsequent consumptive coagulopathy in association with vascular tumours -especially kaposiform hemangioendothelioma/ tufted angiomas. KMS is usually caused by kaposiform hemangio-endothelioma or tufted angioma and other vascular tumours like infantile hemangioma.

KHE and tufted angioma are intermediate locally aggressive childhood vascular tumours that are locally aggressive and often spread to the area around tumour.

Pathophysiology of KMS is poorly understood and complicated. The proposed mechanism involves both primary and secondary hemostatic mechanisms leading to platelet trapping, platelet activation/ aggregation and platelet consumption within the abnormal vascular structures.

We report a case of two day old male child presented with multiple areas of petechial haemorrhage on plantar aspect of both feet, right leg, both upper limbs, forehead and bilateral cheeks and large hemangiomas in left lower limb, lateral pelvic wall and abdominal wall. Hemogram showed thrombocytopenia with platelet count of 20,000/ cumm. Ultrasonography and MRI showed diffuse hemangioma in left leg extending in pelvis along left lateral pelvic wall, medial to the iliacus muscle and extending in the retroperitoneum, encasing aorta upto the level of renal hilum. Diagnosis of kasabach meritt syndrome in Kaposi hemangio-endothelioma was made.

Full Text:



Yadav D, Maheshwari A, Aneja S, Seth A, Chandra J.Neonatal Kasabach-Merritt phenomenon.Indian J Med Paediatr Oncol. 2011 Oct;32(4):238-41.

PMID: 22563162 PMCID: PMC3343255

Lowe LH, Marchant TC, Rivard DC, Scherbel AJ.Vascular malformations: classification and terminology the radiologist needs to know.Semin Roentgenol. 2012 Apr;47(2):106-17.PMID: 22370189

Larsen EC, Zinkham WH, Eggleston JC, Zitelli BJ.Kasabach-Merritt syndrome: therapeutic considerations.Pediatrics. 1987 Jun;79(6):971-80. PMID: 3108848

Osman NM.Kasabach - Merritt syndrome: A case report. Sudan J Paediatr. 2013;13(1):49-52.PMID: 27493358 PMCID: PMC4949964

Hall GW.Kasabach-Merritt syndrome: pathogenesis and management.Br J Haematol. 2001 Mar;112(4):851-62. PMID: 11298580

Rodriguez V, Lee A, Witman PM, Anderson PA.Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.J Pediatr Hematol Oncol. 2009 Jul;31(7):522-6. PMID: 19564750

Ryan C, Price V, John P, Mahant S, Baruchel S, Brandão L, Blanchette V, Pope E, Weinstein M.Kasabach-Merritt phenomenon: a single centre experience.

Eur J Haematol. 2010 Feb 1;84(2):97-104. PMID: 19889011

Croteau SE, Liang MG, Kozakewich HP, Alomari AI, Fishman SJ, Mulliken JB, Trenor CC 3rd.Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals .J Pediatr. 2013 Jan;162(1):142-7. PMID: 22871490 PMCID: PMC3494787

Kelly M. Kasabach-Merritt phenomenon. Pediatr Clin North Am. 2010 Oct;57(5):1085-9.PMID: 20888459

Master S, Kallam D, El-Osta H, Peddi P (2017) Clinical Review: Management of Adult Kasabach-Merritt Syndrome Associated with Hemangiomas . J Blood Disord Transfus ; 8(5): 397

Wen S, Zhang W, Yang Y, Sun J. Angiosarcoma of the scalp and face associated with Kasabach-Merritt syndrome and disseminated intravascular coagulation.

Indian J Dermatol Venereol Leprol. 2016 Jan-Feb;82(1):96-7. PMID: 26728827

Mantovani A, Dejana E.Cytokines as communication signals between leukocytes and endothelial cells.Immunol Today. 1989 Nov;10(11):370-5. PMID: 2514701


  • There are currently no refbacks.

© Copyright PJR 2008-